|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N2800/52 | (2013.01) |
| G01N 33/574 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/57438 | (2013.01) | ||
| G01N 33/74 | (2006.01) | ||
| G01N 33/6863 | (2013.01) | ||
| G01N 33/74 | (2013.01) | ||
| G01N 33/6869 | (2013.01) | ||
| G01N2333/70525 | (2013.01) | ||
| G01N2333/53 | (2013.01) | ||
| G01N2333/54 | (2013.01) | ||
| G01N2333/7155 | (2013.01) | ||
| G01N2333/50 | (2013.01) | ||
| G01N2333/475 | (2013.01) | ||
| G01N2333/4753 | (2013.01) | ||
| G01N2333/515 | (2013.01) | ||
| G01N2333/8146 | (2013.01) |
| (11) | Patento numeris | 3861347 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19790312.3 |
| Europos patento paraiškos padavimo data | 2019-10-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-08-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2019/039012 |
| Data | 2019-10-02 |
| (87) | Numeris | WO 2020/071457 |
| Data | 2020-04-09 |
| (30) | Numeris | Data | Šalis |
| 201862741861 P | 2018-10-05 | US |
| (72) |
FUNAHASHI Yasuhiro , JP
MINOSHIMA Yukinori , JP
KANEKIYO Michio , US
MATSUKI Masahiro , JP
ADACHI Yusuke , JP
KODAMA Kotaro , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS |
| BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS |